Prognostic significance of Holter-derived T wave variability in patients with acute coronary syndrome

Prognostic significance of Holter-derived T wave variability in patients with acute coronary syndrome - TWIST study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015148

Enrollment

1000

Registered

2014-09-16

Start date

2010-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Coronary reperfusion therapy has been performed on the acute coronary syndrome. - Patients who takes renin-angiotensin system inhibitors and beta-blockers. - No history of cardiovascular serious accident(myocardial infarction, stroke, catheter treatment or cardiovascular surgery) in the past three months. - Consent for the study was obtained.

Exclusion criteria

Exclusion criteria: - Patients suffering from malignant disease that is active. - Patients who has pregnancy, breastfeeding or suspected of being pregnant. - Patients who do not obtain written consent. - Pacemaker has been implanted for the treatment of bradyarrhythmias. - If the attending physician has determined ineligible as an object of this study.

Design outcomes

Primary

Measure	Time frame
All cause death	—

Secondary

Measure	Time frame
Cardiovascular death (acute MI, stroke, aortic dissection, systemic emobolism, sudden death), hospitalization due to worsening heart failure, revascularization, lethal arrhythmia, detection new-onset atrial fibrillation, implantation of the defibrillator or pacemaker)	—

Countries

Japan

Contacts

Public ContactEiichi Watanabe

Fujita Health University Department of Cardiology

enwatan@fujita-hu.ac.jp0562-93-2312

Outcome results